Flavonoids: An alternative pathway for the treatment of Alzheimer's disease

被引:11
|
作者
Das, Paramita [1 ]
Preethi, K. [1 ]
Kiruba, A. Angelin [1 ]
Nayak, Anjali [1 ]
机构
[1] Krupanidhi Coll Pharm, Dept Pharm, Bangalore 560035, Karnataka, India
来源
关键词
Alzheimer's; Antioxidant; Dementia; Flavonoids; Tau-phosphorylation; OXIDATIVE STRESS; KAEMPFEROL; MORIN; NEUROINFLAMMATION; MECHANISMS; APIGENIN; FISETIN; GINKGO; RUTIN; TAU;
D O I
10.21276/ap.2021.10.2.33
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Alzheimer's is a non-curative disease that occurs in most of the geriatric patients worldwide. It is one of the top 10 diseases which lead to mortality. According to Indian statistics 2020, the average age for symptoms to occur in Alzheimer's is 66-68 years. Patients can survive up to 8 years after the symptoms of dementia. Women are predominant than men. As there is no permanent treatment for Alzheimer's, but medication and management strategies may temporarily improve. On the basis of clinical trials, it can be suggested that single herbs may offer complementary benefits to the approved drugs. Flavonoids are used prophylactically to treat Alzheimer's, as flavonoids are present in most of the fruits, vegetables, and other daily essential products like apple, berries, spinach, red cabbage, onion, dark chocolate, green tea, etc. Flavonoids are also used to treat early symptoms of Alzheimer's like learning and memory loss as flavonoids cross blood-brain barrier (BBB) and prevent tangles. Natural flavonoids mainly possess antioxidant and neuroprotective action which helps to restore damaged brain cells up to a certain extent. Myricetin, morin. rutin, quercetin, fisetin, ginkgo biloba extract, genistein, kaempferol, apigenin, anthocyanin, glycitein are some of the flavonoids used in prevention of Alzheimer's disease. In present study, we discuss different flavonoids to prevent and treat symptoms that are associated with Alzheimer's disease.
引用
收藏
页码:240 / 251
页数:12
相关论文
共 50 条
  • [41] Treatment for Alzheimer's disease
    Wilcock, GK
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2000, 15 (06) : 562 - 565
  • [42] Treatment of Alzheimer's disease
    Doody, RS
    NEUROLOGIST, 1997, 3 (06) : 333 - 343
  • [43] Treatment of Alzheimer's disease
    Basun, H
    NORDIC JOURNAL OF PSYCHIATRY, 2004, 58 (02) : 90 - 90
  • [44] A disease-modifying treatment for Alzheimer's disease: focus on the trans-sulfuration pathway
    Berry, Thomas
    Abohamza, Eid
    Moustafa, Ahmed A.
    REVIEWS IN THE NEUROSCIENCES, 2020, 31 (03) : 319 - 334
  • [45] The UFMylation pathway is impaired in Alzheimer's disease
    Yan, Tingxiang
    Heckman, Michael G.
    Craver, Emily C.
    Liu, Chia-Chen
    Rawlinson, Bailey D.
    Wang, Xue
    Murray, Melissa E.
    Dickson, Dennis W.
    Ertekin-Taner, Nilufer
    Lou, Zhenkun
    Bu, Guojun
    Springer, Wolfdieter
    Fiesel, Fabienne C.
    MOLECULAR NEURODEGENERATION, 2024, 19 (01)
  • [46] Kynurenine Pathway Metabolites in Alzheimer's Disease
    Giil, Lasse Melvaer
    Midttun, Oivind
    Refsum, Helga
    Ulvik, Arve
    Advani, Rajiv
    Smith, A. David
    Ueland, Per Magne
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 60 (02) : 495 - 504
  • [47] The Amyloid-β Pathway in Alzheimer's Disease
    Hampel, Harald
    Hardy, John
    Blennow, Kaj
    Chen, Christopher
    Perry, George
    Kim, Seung Hyun
    Villemagne, Victor L.
    Aisen, Paul
    Vendruscolo, Michele
    Iwatsubo, Takeshi
    Masters, Colin L.
    Cho, Min
    Lannfelt, Lars
    Cummings, Jeffrey L.
    Vergallo, Andrea
    MOLECULAR PSYCHIATRY, 2021, 26 (10) : 5481 - 5503
  • [48] The Amyloid-β Pathway in Alzheimer’s Disease
    Harald Hampel
    John Hardy
    Kaj Blennow
    Christopher Chen
    George Perry
    Seung Hyun Kim
    Victor L. Villemagne
    Paul Aisen
    Michele Vendruscolo
    Takeshi Iwatsubo
    Colin L. Masters
    Min Cho
    Lars Lannfelt
    Jeffrey L. Cummings
    Andrea Vergallo
    Molecular Psychiatry, 2021, 26 : 5481 - 5503
  • [49] INVOLVEMENT OF THE KYNURENINE PATHWAY IN ALZHEIMER'S DISEASE
    Guillemin, G. J.
    Rahman, A.
    Ting, K.
    Cullen, K. M.
    Braidy, N.
    Chung, R. S.
    Wu, W.
    Brew, B. J.
    JOURNAL OF NEUROCHEMISTRY, 2010, 115 : 39 - 39
  • [50] Current diagnostic pathway for Alzheimer's disease
    Gorzkowska, Agnieszka
    Klimkowicz-Mrowiec, Aleksandra
    AKTUALNOSCI NEUROLOGICZNE, 2023, 23 (04): : 125 - 130